J
Jeroen Janssen
Researcher at VU University Amsterdam
Publications - 276
Citations - 9440
Jeroen Janssen is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Myeloid leukemia & Transplantation. The author has an hindex of 44, co-authored 255 publications receiving 7099 citations. Previous affiliations of Jeroen Janssen include Vrije Universiteit Brussel & Radboud University Nijmegen.
Papers
More filters
Journal ArticleDOI
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Andreas Hochhaus,Michele Baccarani,Richard T. Silver,Charles A. Schiffer,Jane F. Apperley,Francisco Cervantes,Richard E. Clark,Jorge E. Cortes,Michael W. Deininger,François Guilhot,Henrik Hjorth-Hansen,Timothy P. Hughes,Jeroen Janssen,Hagop M. Kantarjian,Dong-Wook Kim,Richard A. Larson,Jeffrey H. Lipton,Francois-Xavier Mahon,Jiří Mayer,Franck E. Nicolini,Dietger Niederwieser,Fabrizio Pane,Jerald P. Radich,Delphine Rea,Johan Richter,Gianantonio Rosti,Philippe Rousselot,Giuseppe Saglio,Susanne Saußele,Simona Soverini,Juan Luis Steegmann,Anna G. Turkina,Andrey Zaritskey,Ruediger Hehlmann +33 more
TL;DR: An expert panel to critically evaluate and update the evidence to achieve goals to achieve a stable deep molecular response (DMR) and discontinuing medication for treatment-free remission (TFR) in chronic myeloid leukemia.
Journal ArticleDOI
Chronic myeloid leukaemia : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Andreas Hochhaus,Susanne Saussele,Giovanni Rosti,Francois-Xavier Mahon,Jeroen Janssen,Henrik Hjorth-Hansen,Johan Richter,Christian Buske +7 more
TL;DR: Proof of diagnosis is attained by demonstration of thePhiladelphia (Ph) chromosome (22q-) resulting from thebalanced translocation t(9;22) (q34;q11), and/or the BCR-ABLrearrangement in peripheral blood or bone marrow cells.
Journal ArticleDOI
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
Susanne Saussele,Johan Richter,Joelle Guilhot,Franz Gruber,Henrik Hjorth-Hansen,Antonio Almeida,Jeroen Janssen,Jiri Mayer,Perttu Koskenvesa,Panayiotis Panayiotidis,Ulla Olsson-Strömberg,Joaquin Martinez-Lopez,Philippe Rousselot,Hanne Vestergaard,Hans Ehrencrona,Veli Kairisto,Katerina Machova Polakova,Martin Müller,Satu Mustjoki,Marc G. Berger,Alice Fabarius,Wolf-Karsten Hofmann,Andreas Hochhaus,Markus Pfirrmann,Francois-Xavier Mahon,Gert J. Ossenkoppele,Maria Pagoni,Stina Söderlund,Martine Escoffre-Barbe,Gabriel Etienne,Jolanta Dengler,Françoise Huguet,Nikolas von Bubnoff,Hana Klamova,Edgar Faber,François Guilhot,Kourosh Lotfi,Delphine Rea,Tim H. Brümmendorf,Gorgine E. de Greef,Leif Stenke,Franck E. Nicolini,Laurence Legros,Andreas Burchert,Jaroslava Voglová,Aude Charbonnier,Emmanuel Gyan,Volker Kunzmann,Peter E. Westerweel +48 more
TL;DR: In this paper, a prospective, non-randomised trial was conducted at 61 European centres in 11 countries to investigate the impact of stopping TKI therapy on the survival of patients with chronic myeloid leukaemia.
Journal ArticleDOI
Automatic processes and the appraisal of sexual stimuli: Toward an information processing model of sexual arousal
TL;DR: In this article, a model of sexual arousal is presented that highlights the interaction between automatic and controlled cognitive processes and proposes that different levels of cognitive processing can differentially affect subjective and physiological sexual arousal.
Journal ArticleDOI
Visualization of participation: Does it contribute to successful computer-supported collaborative learning?
TL;DR: The results of this study demonstrate that visualization of participation can contribute to successful CSCL.